• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    RLX Technology Announces Unaudited Second Quarter 2025 Financial Results

    8/22/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $RLX alert in real time by email

    SHENZHEN, China, Aug. 22, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the second quarter ended June 30, 2025.

    Second Quarter 2025 Financial Highlights

    • Net revenues were RMB880.0 million (US$122.8 million) in the second quarter of 2025, compared with RMB627.2 million in the same period of 2024.
    • Gross margin was 27.5% in the second quarter of 2025, compared with 25.2% in the same period of 2024.
    • Non-GAAP income from operations[1] was RMB116.2 million (US$16.2 million) in the second quarter of 2025, compared with RMB46.9 million in the same period of 2024.
    • U.S. GAAP net income was RMB218.5 million (US$30.5 million) in the second quarter of 2025, compared with RMB134.9 million in the same period of 2024.
    • Non-GAAP net income1 was RMB291.2 million (US$40.6 million) in the second quarter of 2025, compared with RMB214.8 million in the same period of 2024.

    "We are pleased to deliver another strong performance this quarter, thanks to our effective strategy execution and solid progress in our international expansion amid ongoing transformation in the global e-vapor industry." commented Ms. Ying (Kate) Wang, Co-founder, Chairperson of the Board of Directors, and Chief Executive Officer of RLX Technology. "Rapid shifts in regulation and consumer behavior are remolding the competitive landscape while unlocking new opportunities for growth, innovation and long-term market development. As a trusted e-vapor brand for adult smokers worldwide, we have reinforced our leadership in this dynamic environment by prioritizing global compliance, implementing data-driven localized strategies, and deepening strategic partnerships to strengthen our international distribution. Moving forward, we remain confident in our ability to navigate complexity and seize emerging opportunities, creating sustainable value and delivering long-term benefits to all stakeholders as we shape the future of the global industry."

    Mr. Chao Lu, Chief Financial Officer of RLX Technology, added, "Our robust second quarter results were led by 40.3% year-over-year and 8.9% sequential net revenues growth to RMB880.0 million, propelled by the sustained momentum in our international expansion. Furthermore, our disciplined cost control and optimized product mix resulted in an impressive 147.6% year-over-year increase in non-GAAP income from operations to RMB 116.2 million. Supported by an effective global growth strategy, efficient operations, and a deep commitment to innovation, we are well-positioned to continue driving sustainable, profitable development and generate long-term shareholder value."

    Second Quarter 2025 Financial Results

    Net revenues were RMB880.0 million (US$122.8 million) in the second quarter of 2025, compared with RMB627.2 million in the same period of 2024. The increase was mainly driven by our expansion into international markets.

    Gross profit was RMB242.1 million (US$33.8 million) in the second quarter of 2025, compared with RMB157.9 million in the same period of 2024.

    Gross margin was 27.5% in the second quarter of 2025, compared with 25.2% in the same period of 2024. The increase was primarily due to a favorable change in revenue mix and margin improvement in selected Asian countries.

    Operating expenses were RMB203.1 million (US$28.4 million) in the second quarter of 2025, compared with RMB191.2 million in the same period of 2024. The increase was primarily due to an increase in salaries and welfare expenses, slightly offset by an overall decrease in share-based compensation expenses.

    Selling expenses were RMB84.6 million (US$11.8 million) in the second quarter of 2025, compared with RMB62.2 million in the same period of 2024, primarily due to an increase in salaries and welfare, and branding expenses.

    General and administrative expenses were RMB88.4 million (US$12.3 million) in the second quarter of 2025, compared with RMB129.0 million in the same period of 2024, primarily due to a decrease in share-based compensation expenses, slightly offset by an increase in salaries and welfare expenses.

    Research and development expenses were RMB30.1 million (US$4.2 million) in the second quarter of 2025, compared with positive RMB0.04 million in the same period of 2024, primarily due to an increase in share-based compensation expenses.

    U.S. GAAP income from operations was RMB39.0 million (US$5.4 million) in the second quarter of 2025, compared with U.S. GAAP loss from operations of RMB33.3 million in the same period of 2024.

    Non-GAAP income from operations was RMB116.2 million (US$16.2 million) in the second quarter of 2025, compared with RMB46.9 million in the same period of 2024.

    Income tax expense was RMB28.5 million (US$4.0 million) in the second quarter of 2025, compared with RMB21.4 million in the same period of 2024.

    U.S. GAAP net income was RMB218.5 million (US$30.5 million) in the second quarter of 2025, compared with RMB134.9 million in the same period of 2024.

    Non-GAAP net income was RMB291.2 million (US$40.6 million) in the second quarter of 2025, compared with RMB214.8 million in the same period of 2024.

    U.S. GAAP basic and diluted net income per American depositary share ("ADS") were RMB0.178 (US$0.025) and RMB0.166 (US$0.023), respectively, in the second quarter of 2025, compared with U.S. GAAP basic and diluted net income per ADS of RMB0.108 and RMB0.103, respectively, in the same period of 2024.

    Non-GAAP basic and diluted net income per ADS[2] were RMB0.234 (US$0.033) and RMB0.218(US$0.030), respectively, in the second quarter of 2025, compared with non-GAAP basic and diluted net income per ADS of RMB0.173 and RMB0.165, respectively, in the same period of 2024.

    Balance Sheet and Cash Flow

    As of June 30, 2025, the Company had cash and cash equivalents, restricted cash, short-term bank deposits, net, short-term investments, net, long-term bank deposits, net and long-term investment securities, net of RMB15,524.3 million (US$2,167.1 million), compared with RMB16,159.6 million as of March 31, 2025. In the second quarter of 2025, net cash generated from operating activities was RMB229.6 million (US$32.1 million).

    Dividend Payment

    The Company announced that its Board of Directors approved a cash dividend of US$0.01 per ordinary share, or US$0.01 per ADS, to holders of ordinary shares and holders of ADSs, respectively, as of the close of business on September 12, 2025 Beijing/Hong Kong Time and New York Time, respectively, payable in U.S. dollars. The payment date is expected to be on or around September 19, 2025 and on or around September 26, 2025 for holders of ordinary shares and holders of ADSs, respectively.

    Conference Call

    The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on August 22, 2025 (8:00 PM Beijing/Hong Kong Time on August 22, 2025).

    Dial-in details for the earnings conference call are as follows:

    United States (toll-free):

    +1-888-317-6003

    International:

    +1-412-317-6061

    Hong Kong, China (toll-free):

    +800-963-976

    Hong Kong, China:

    +852-5808-1995

    Mainland China:

    400-120-6115

    Participant Code:

    3841228

    Participants should dial in 10 minutes before the scheduled start time and ask to be connected to the call for "RLX Technology Inc." with the Participant Code as set forth above.

    Additionally, a live and archived webcast of the conference call will be available on the Company's investor relations website at https://ir.relxtech.com.

    A replay of the conference call will be accessible approximately two hours after the conclusion of the call until August 29, 2025, by dialing the following telephone numbers:

    United States:

    +1-877-344-7529

    International:

    +1-412-317-0088

    Replay Access Code:          

    2624638

    About RLX Technology Inc.

    RLX Technology Inc. (NYSE:RLX) is a leading global branded e-vapor company. The Company leverages its strong in-house technology, product development capabilities and in-depth insights into adult smokers' needs to develop superior e-vapor products.

    For more information, please visit: http://ir.relxtech.com.

    Non-GAAP Financial Measures

    The Company uses non-GAAP net income, non-GAAP income from operations and non-GAAP basic and diluted net income per ADS, each a non-GAAP financial measure, in evaluating its operating results and for financial and operational decision-making purposes. Non-GAAP net income represents net income excluding share-based compensation expenses, amortization and depreciation of assets arising from fair value step up in business acquisitions, and tax effects on non-GAAP adjustments. Non-GAAP income from operations represents net income from operations excluding share-based compensation expenses and amortization and depreciation of assets arising from fair value step up in business acquisitions. Non-GAAP basic and diluted net income per ADS is computed using non-GAAP net income attributable to RLX Technology Inc. and the same number of ADSs used in U.S. GAAP basic and diluted net income per ADS calculation.

    The Company presents these non-GAAP financial measures because they are used by the management to evaluate its operating performance and formulate business plans. The Company believes that they help identify underlying trends in its business that could otherwise be distorted by the effect of certain expenses that are included in net income. The Company also believes that the use of the non-GAAP measures facilitates investors' assessment of its operating performance, as they could provide useful information about its operating results, enhances the overall understanding of its past performance and future prospects, and allows for greater visibility with respect to key metrics used by the management in its financial and operational decision making.

    The non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. The non-GAAP financial measures have limitations as analytical tools. They should not be considered in isolation or construed as an alternative to net income, basic and diluted net income per ADS or any other measure of performance or as an indicator of its operating performance. Investors are encouraged to review its historical non-GAAP financial measures to the most directly comparable U.S. GAAP measures. The non-GAAP financial measures here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting their usefulness as comparative measures to our data. The Company encourages investors and others to review its financial information in its entirety and not rely on any single financial measure.

    For more information on the non-GAAP financial measures, please see the table captioned "Unaudited Reconciliation of GAAP and non-GAAP Results" set forth at the end of this press release.

    Exchange Rate Information

    This announcement contains translations of certain RMB amounts into U.S. dollars at a specified rate solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars and from U.S. dollars to RMB are made at a rate of RMB7.1636 to US$1.00, the exchange rate on June 30, 2025, set forth in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or U.S. dollar amounts referred could be converted into U.S. dollars or RMB, as the case may be, at any particular rate or at all.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "potential," "continue" and similar statements. Among other things, quotations from management in this announcement, as well as the Company's strategic and operational plans, contain forward-looking statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; trends and competition in the global e-vapor market; changes in its revenues and certain cost or expense items; governmental policies, laws and regulations across various jurisdictions relating to the Company's industry, and general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is current as of the date of this press release, and the Company does not undertake any obligation to update such information, except as required under applicable law.

    For more information, please contact:

    In China:

    RLX Technology Inc.

    Head of Capital Markets

    Sam Tsang

    Email: [email protected]

    Piacente Financial Communications

    Jenny Cai

    Tel: +86-10-6508-0677

    Email: [email protected] 

    In the United States:

    Piacente Financial Communications

    Brandi Piacente

    Tel: +1-212-481-2050

    Email: [email protected] 

    [1] Non-GAAP net income and non-GAAP income from operations are non-GAAP financial measures. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.

    [2] Non-GAAP basic and diluted net income per ADS is a non-GAAP financial measure. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    (All amounts in thousands)











    As of



    December 31,

    June 30,

    June 30,



    2024

    2025

    2025



    RMB

    RMB

    US$

    ASSETS







    Current assets:







    Cash and cash equivalents

    5,593,492

    3,858,010

    538,557

    Restricted cash

    50,867

    101,346

    14,147

    Short-term bank deposits, net

    2,179,886

    2,148,125

    299,867

    Receivables from online payment platforms

    4,722

    8,826

    1,232

    Short-term investments

    719,755

    1,407,025

    196,413

    Accounts and notes receivable, net

    78,484

    236,247

    32,979

    Inventories

    142,552

    227,857

    31,808

    Amounts due from related parties

    346,132

    161,966

    22,610

    Prepayments and other current assets, net

    185,091

    216,011

    30,154

    Total current assets

    9,300,981

    8,365,413

    1,167,767

    Non-current assets:







    Property, equipment and leasehold improvement, net

    50,787

    171,954

    24,004

    Intangible assets, net

    52,796

    244,731

    34,163

    Long-term investments, net

    8,000

    8,330

    1,163

    Deferred tax assets, net

    38,067

    41,588

    5,805

    Right-of-use assets, net

    24,110

    56,634

    7,906

    Long-term bank deposits, net

    727,448

    620,388

    86,603

    Long-term investment securities, net

    6,599,365

    7,389,444

    1,031,527

    Goodwill

    59,581

    572,041

    79,854

    Other non-current assets, net

    9,914

    15,724

    2,195

    Total non-current assets

    7,570,068

    9,120,834

    1,273,220

    Total assets

    16,871,049

    17,486,247

    2,440,987









    LIABILITIES AND SHAREHOLDERS' EQUITY







    Current liabilities:







    Accounts and notes payable

    458,538

    357,038

    49,841

    Contract liabilities

    10,610

    94,075

    13,132

    Salary and welfare benefits payable

    73,740

    52,178

    7,284

    Taxes payable

    126,154

    191,073

    26,673

    Short-term loan

    40,000

    104,114

    14,534

    Accrued expenses and other current liabilities

    108,816

    150,527

    21,012

    Amounts due to related parties

    27,401

    30,045

    4,194

    Dividend payable

    1,144

    -

    -

    Lease liabilities - current portion

    11,447

    22,647

    3,161

    Total current liabilities

    857,850

    1,001,697

    139,831









    Non-current liabilities:







    Deferred tax liabilities

    16,196

    123,092

    17,183

    Lease liabilities - non-current portion

    7,050

    31,289

    4,368

    Other non-current liability

    -

    90,759

    12,670

    Total non-current liabilities

    23,246

    245,140

    34,221

    Total liabilities

    881,096

    1,246,837

    174,052









    Shareholders' Equity:







    Total RLX Technology Inc. shareholders' equity

    15,988,216

    16,151,718

    2,254,692

    Noncontrolling interests

    1,737

    87,692

    12,243

    Total shareholders' equity

    15,989,953

    16,239,410

    2,266,935









    Total liabilities and shareholders' equity

    16,871,049

    17,486,247

    2,440,987

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

    (All amounts in thousands, except for share and per share data)





















    For the three months ended



    For the six months ended



    June 30

    March 31,

    June 30,

    June 30,



    June 30,

    June 30,

    June 30,



    2024

    2025

    2025

    2025



    2024

    2025

    2025



    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$



















    Net revenues

    627,176

    808,300

    879,952

    122,836



    1,178,799

    1,688,252

    235,671

    Cost of revenues

    (400,712)

    (477,526)

    (552,037)

    (77,061)



    (728,322)

    (1,029,563)

    (143,721)

    Excise tax on products

    (68,602)

    (99,823)

    (85,835)

    (11,982)



    (149,842)

    (185,658)

    (25,917)

    Gross profit

    157,862

    230,951

    242,080

    33,793



    300,635

    473,031

    66,033



















    Operating expenses:

















    Selling expenses

    (62,235)

    (58,989)

    (84,649)

    (11,817)



    (115,122)

    (143,638)

    (20,051)

    General and administrative expenses

    (128,997)

    (67,468)

    (88,406)

    (12,341)



    (238,951)

    (155,874)

    (21,759)

    Research and development expenses

    40

    (27,055)

    (30,067)

    (4,197)



    (31,500)

    (57,122)

    (7,974)

    Total operating expenses

    (191,192)

    (153,512)

    (203,122)

    (28,355)



    (385,573)

    (356,634)

    (49,784)



















    (Loss)/income from operations

    (33,330)

    77,439

    38,958

    5,438



    (84,938)

    116,397

    16,249



















    Other income:

















    Interest income, net

    154,207

    135,953

    142,851

    19,941



    313,065

    278,804

    38,920

    Investment income 

    12,718

    8,386

    24,832

    3,466



    25,494

    33,218

    4,637

    Others, net

    22,739

    29,143

    40,324

    5,629



    51,682

    69,467

    9,697

    Income before income tax

    156,334

    250,921

    246,965

    34,474



    305,303

    497,886

    69,503

    Income tax expense

    (21,389)

    (28,181)

    (28,470)

    (3,974)



    (37,733)

    (56,651)

    (7,908)

    Net income

    134,945

    222,740

    218,495

    30,500



    267,570

    441,235

    61,595

    Less: net income attributable to noncontrolling interests

    2,631

    700

    1,378

    192



    3,348

    2,078

    290

    Net income attributable to RLX Technology Inc.

    132,314

    222,040

    217,117

    30,308



    264,222

    439,157

    61,305

    Other comprehensive income/(loss):

















    Foreign currency translation adjustments

    44,174

    (15,671)

    (26,510)

    (3,701)



    56,880

    (42,181)

    (5,888)

    Unrealized income on long-term investment securities

    705

    2,067

    698

    97



    692

    2,765

    386

    Total other comprehensive income/(loss)

    44,879

    (13,604)

    (25,812)

    (3,604)



    57,572

    (39,416)

    (5,502)

    Total comprehensive income

    179,824

    209,136

    192,683

    26,896



    325,142

    401,819

    56,093

    Less: total comprehensive income/(loss) attributable to

         noncontrolling interests

    2,618

    636

    632

    88



    3,348

    1,268

    177

    Total comprehensive income attributable to RLX Technology Inc.

    177,206

    208,500

    192,051

    26,808



    321,794

    400,551

    55,916



















    Net income per ordinary share/ADS 

















     Basic

    0.108

    0.181

    0.178

    0.025



    0.213

    0.359

    0.050

     Diluted

    0.103

    0.170

    0.166

    0.023



    0.205

    0.335

    0.047



















    Weighted average number of ordinary shares/ADSs

















    Basic

    1,228,869,526

    1,226,330,482

    1,221,705,674

    1,221,705,674



    1,239,093,583

    1,224,005,302

    1,224,005,302

    Diluted

    1,284,388,803

    1,308,811,866

    1,309,486,924

    1,309,486,924



    1,290,853,297

    1,309,617,920

    1,309,617,920

     

    RLX TECHNOLOGY INC.

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

    (All amounts in thousands, except for share and per share data)













    For the three months ended



    For the six months ended



    June 30,

    March 31,

    June 30,

    June 30,



    June 30,

    June 30,

    June 30



    2024

    2025

    2025

    2025



    2024

    2025

    2025



    (As adjusted) (a)

    (As adjusted) (a)







    (As adjusted) (a)







    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$

    (Loss)/income from operations

    (33,330)

    77,439

    38,958

    5,438



    (84,938)

    116,397

    16,249

    Add: share-based compensation expenses

















             Selling expenses

    9,172

    3,310

    13,262

    1,851



    13,775

    16,572

    2,313

             General and administrative expenses

    93,026

    24,271

    38,368

    5,356



    159,440

    62,639

    8,744

             Research and development expenses

    (24,074)

    745

    7,188

    1,003



    (20,193)

    7,933

    1,107

    Amortization and depreciation of assets arising from fair value step

    up in business acquisitions

















    Cost of revenues

    -

    -

    13,347

    1,863



    -

    13,347

    1,863

    Selling expenses

    2,103

    2,003

    4,881

    681



    4,263

    6,884

    961

    General and administrative expenses

    30

    28

    167

    23



    60

    195

    27

    Non-GAAP income from operations

    46,927

    107,796

    116,171

    16,215



    72,407

    223,967

    31,264



















    Net income

    134,945

    222,740

    218,495

    30,500



    267,570

    441,235

    61,595

    Add: share-based compensation expenses

    78,124

    28,326

    58,818

    8,210



    153,022

    87,144

    12,164

    Amortization and depreciation of assets arising from fair value step

    up in business acquisitions

    2,133

    2,031

    18,395

    2,567



    4,323

    20,426

    2,851

    Tax effects on non-GAAP adjustments

    (446)

    (425)

    (4,513)

    (630)



    (904)

    (4,938)

    (689)

    Non-GAAP net income

    214,756

    252,672

    291,195

    40,647



    424,011

    543,867

    75,921



















    Net income attributable to RLX Technology Inc.

    132,314

    222,040

    217,117

    30,308



    264,222

    439,157

    61,305

    Add: share-based compensation expenses

    78,124

    28,326

    58,818

    8,210



    153,022

    87,144

    12,164

    Amortization and depreciation of assets arising from fair value step

    up in business acquisitions(b)

    2,133

    2,031

    13,002

    1,815



    4,323

    15,033

    2,099

    Tax effects on non-GAAP adjustments(b)

    (446)

    (425)

    (3,164)

    (442)



    (904)

    (3,589)

    (501)

    Non-GAAP net income attributable to RLX Technology Inc.

    212,125

    251,972

    285,773

    39,891



    420,663

    537,745

    75,067



















    Non-GAAP net income per ordinary share/ADS

















    - Basic

    0.173

    0.205

    0.234

    0.033



    0.339

    0.439

    0.061

    - Diluted

    0.165

    0.193

    0.218

    0.030



    0.326

    0.411

    0.057

    Weighted average number of ordinary shares/ADSs

















    - Basic

    1,228,869,526

    1,226,330,482

    1,221,705,674

    1,221,705,674



    1,239,093,583

    1,224,005,302

    1,224,005,302

    - Diluted

    1,284,388,803

    1,308,811,866

    1,309,486,924

    1,309,486,924



    1,290,853,297

    1,309,617,920

    1,309,617,920



















    Note (a): The Company completed the acquisition of the acquired company on May 31, 2025, which was accounted for as a business combination. Beginning in Q2 2025, the Company included the amortization and

    depreciation of assets arising from fair value step up in business acquisitions, as well as the associated tax impact, in the reconciliation items for GAAP and Non-GAAP results. The Company has retrospectively

    adjusted the above unaudited reconciliation of GAAP and Non-GAAP results for the prior quarter. The Company believes these changes provide management and investors with more useful information to evaluate

    the operations of its business.

    Note (b): The amortization and depreciation expense and related tax effect attributable to noncontrolling interests has been excluded from the presentation in the reconciliation items for GAAP and Non-GAAP

    results.

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (All amounts in thousands)





















    For the three months ended



    For the six months ended



    June 30,

    March 31,

    June 30

    June 30,



    June 30,

    June 30,

    June 30,



    2024

    2025

    2025

    2025



    2024

    2025

    2025



    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$

    Net cash generated from operating activities

    196,764

    207,165

    229,616

    32,053



    200,784

    436,781

    60,972

    Net cash generated/(used in) from investing

         activities

    557,132

    (987,166)

    (816,501)

    (113,979)



    977,797

    (1,803,667)

    (251,782)

    Net cash generated/(used in) from financing

         activities

    -

    14,435

    (326,948)

    (45,640)



    (472,885)

    (312,513)

    (43,625)

    Effect of foreign exchange rate changes on cash,

         cash equivalents and restricted cash

    10,032

    (8,040)

    2,436

    339



    12,935

    (5,604)

    (783)

    Net increase in cash and cash equivalents and

         restricted cash

    763,928

    (773,606)

    (911,397)

    (127,227)



    718,631

    (1,685,003)

    (235,218)

    Cash, cash equivalents and restricted cash at

         the beginning of the period

    2,374,761

    5,644,359

    4,870,753

    679,931



    2,420,058

    5,644,359

    787,922

    Cash, cash equivalents and restricted cash at

         the end of the period

    3,138,689

    4,870,753

    3,959,356

    552,704



    3,138,689

    3,959,356

    552,704

     

    Cision View original content:https://www.prnewswire.com/news-releases/rlx-technology-announces-unaudited-second-quarter-2025-financial-results-302536494.html

    SOURCE RLX Technology Inc.

    Get the next $RLX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RLX

    DatePrice TargetRatingAnalyst
    3/17/2025$2.80 → $2.50Buy → Neutral
    Citigroup
    8/8/2023$2.60Buy
    UBS
    More analyst ratings

    $RLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RLX Technology Announces Unaudited Second Quarter 2025 Financial Results

    SHENZHEN, China, Aug. 22, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net revenues were RMB880.0 million (US$122.8 million) in the second quarter of 2025, compared with RMB627.2 million in the same period of 2024.Gross margin was 27.5% in the second quarter of 2025, compared with 25.2% in the same period of 2024.Non-GAAP income from operations[1] was RMB116.2 million (US$16.2 million) in the second quarter of 2025, compared with RMB46.9 million in the same period of 2024.U.S

    8/22/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology to Report Second Quarter 2025 Financial Results on August 22, 2025

    - Earnings Call Scheduled for 8:00 a.m. ET on August 22, 2025 - SHENZHEN, China, Aug. 5, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2025, before the U.S. markets open on Friday, August 22, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on August 22, 2025 (8:00 PM Beijing/Hong Kong Time on August 22, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Ko

    8/5/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology Announces Unaudited First Quarter 2025 Financial Results

    SHENZHEN, China, May 16, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenues were RMB808.3 million (US$111.4 million) in the first quarter of 2025, compared with RMB551.6 million in the same period of 2024.Gross margin was 28.6% in the first quarter of 2025, compared with 25.9% in the same period of 2024.U.S. GAAP net income was RMB222.7 million (US$30.7 million) in the first quarter of 2025, compared with RMB132.6 million in the same period of 2024.Non-GAAP net income[1

    5/16/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    SEC Filings

    View All

    SEC Form 6-K filed by RLX Technology Inc.

    6-K - RLX Technology Inc. (0001828365) (Filer)

    8/22/25 7:09:03 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by RLX Technology Inc.

    6-K - RLX Technology Inc. (0001828365) (Filer)

    5/16/25 6:02:23 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 20-F filed by RLX Technology Inc.

    20-F - RLX Technology Inc. (0001828365) (Filer)

    4/17/25 4:01:47 PM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RLX Technology downgraded by Citigroup with a new price target

    Citigroup downgraded RLX Technology from Buy to Neutral and set a new price target of $2.50 from $2.80 previously

    3/17/25 7:42:34 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    UBS initiated coverage on RLX Technology with a new price target

    UBS initiated coverage of RLX Technology with a rating of Buy and set a new price target of $2.60

    8/8/23 9:12:45 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    Financials

    Live finance-specific insights

    View All

    RLX Technology Announces Unaudited Second Quarter 2025 Financial Results

    SHENZHEN, China, Aug. 22, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net revenues were RMB880.0 million (US$122.8 million) in the second quarter of 2025, compared with RMB627.2 million in the same period of 2024.Gross margin was 27.5% in the second quarter of 2025, compared with 25.2% in the same period of 2024.Non-GAAP income from operations[1] was RMB116.2 million (US$16.2 million) in the second quarter of 2025, compared with RMB46.9 million in the same period of 2024.U.S

    8/22/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology to Report Second Quarter 2025 Financial Results on August 22, 2025

    - Earnings Call Scheduled for 8:00 a.m. ET on August 22, 2025 - SHENZHEN, China, Aug. 5, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2025, before the U.S. markets open on Friday, August 22, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on August 22, 2025 (8:00 PM Beijing/Hong Kong Time on August 22, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Ko

    8/5/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    RLX Technology Announces Unaudited First Quarter 2025 Financial Results

    SHENZHEN, China, May 16, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenues were RMB808.3 million (US$111.4 million) in the first quarter of 2025, compared with RMB551.6 million in the same period of 2024.Gross margin was 28.6% in the first quarter of 2025, compared with 25.9% in the same period of 2024.U.S. GAAP net income was RMB222.7 million (US$30.7 million) in the first quarter of 2025, compared with RMB132.6 million in the same period of 2024.Non-GAAP net income[1

    5/16/25 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    $RLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/7/24 6:06:29 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/6/24 4:01:28 PM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

    SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

    2/14/23 6:01:42 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care